全身性エリテマトーデス(SLE)治療薬市場:薬剤クラス別(抗マラリア薬、非ステロイド性抗炎症薬(NSAIDS)、細胞障害性・免疫抑制薬、生物学的製剤、その他)、投与形態別(静脈内、皮下、経口)、地域別 2024-2032Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2024-2032 全身性エリテマトーデス(SLE)治療薬の世界市場規模は2023年に27億米ドルに達した。今後、IMARC Groupは、市場が2032年までに45億米ドルに達し、2024年から2032年の間に5.83%の成長率(CAGR)を示すと予測してい... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー全身性エリテマトーデス(SLE)治療薬の世界市場規模は2023年に27億米ドルに達した。今後、IMARC Groupは、市場が2032年までに45億米ドルに達し、2024年から2032年の間に5.83%の成長率(CAGR)を示すと予測している。SLEに罹患する患者数の増加、国民の意識向上キャンペーンの高まり、ジェネリック医薬品の容易な入手が市場を牽引する主な要因のいくつかである。全身性エリテマトーデス(SLE)は、多彩な臨床症状、多系統炎症(MIS)、再発寛解型経過(RRMS)を特徴とする自己免疫疾患である。SLEは、皮膚、関節、腎臓、脳など身体の多くの部位に発症する。一般に、さまざまな遺伝的、環境的、ホルモン的要因によって引き起こされる。症状としては、疲労、関節痛や腫れ、頭痛、発疹、脱毛、貧血、血液凝固、発熱などがあります。SLEは症状評価、身体診察、胸部X線検査、尿検査、血液検査などを行い、医療従事者によって診断されます。関節の痛みやこわばりには抗炎症薬を、発疹にはステロイドクリームを、免疫反応を抑えるには副腎皮質ステロイドを、皮膚のトラブルには抗マラリア薬を使用して症状を緩和します。さらに重症の場合は、疾患修飾薬や標的免疫系薬剤を使用する。このほか、免疫系の活動を抑制する様々な免疫抑制剤を用いて治療する。 全身性エリテマトーデス(SLE)治療薬の市場動向: 自己免疫疾患の有病率の増加やSLE患者の増加は、世界中でSLE治療薬の需要を牽引している主な要因の一つである。さらに、研究機関や診断機関の数は増加傾向にあり、SLEとその可能な治療法について一般の人々を啓蒙するキャンペーンを実施している。さらに、各国の政府や非政府組織(NGO)は、新規治療薬の開発やSLE治療に関連する創薬標的を特定するための様々なプログラムに投資しています。これに加え、医療インフラや診断技術を改善するための資金が世界的に増加していることが、市場の成長を促している。これとは別に、SLEに伴う痛み、炎症、こわばりを和らげるための様々なジェネリック医薬品が、オフラインやオンラインの小売チャネルを通じて簡単に入手できることも、市場の成長を後押ししている。一般に、アスピリン、イブプロフェン(Motrin)、ナプロキセン、セレコキシブ(Celebrex)、ジクロフェナク(Voltaren)、ジフルニサール(Dolobid)、ピロキシカム(Feldene)などの市販薬(OTC)や処方箋ベースの非ステロイド性抗炎症薬(NSAIDs)が使用されている。さらに、ヒドロキシクロロキン製剤の使用増加が市場成長に寄与している。このほか、SLEの早期診断・早期治療の利点に対する個人や医療従事者の意識の高まりが、SLE治療薬の売上全体に影響を与えている。 主な市場セグメンテーション IMARC Groupは、世界の全身性エリテマトーデス(SLE)治療薬市場の各セグメントにおける主要動向の分析と、2024年から2032年までの世界、地域、国レベルでの予測を掲載しています。当レポートでは、薬剤クラスとデリバリー様式に基づいて市場を分類しています。 薬剤クラスの洞察 抗マラリア薬 クロロキン ヒドロキシクロロキン 非ステロイド性抗炎症薬(NSAIDS) 細胞毒性薬および免疫抑制薬 シクロホスファミド メトトレキサート ミコフェノール酸モフェチル タクロリムス シクロスポリン 生物製剤 その他 本レポートでは、全身性エリテマトーデス(SLE)治療薬市場を薬剤クラス別に詳細に分類・分析しています。これには抗マラリア薬(クロロキン、ヒドロキシコロキン)、非ステロイド性抗炎症薬(NSAIDS)、細胞毒性・免疫抑制薬(シクロファミド、メトトレキサート、ミコフェノール酸モフェチル、タクロリムス、シクロスポリン)、生物学的製剤、その他が含まれる。報告書によると、細胞毒性・免疫抑制剤が最大のセグメントを占めている。 送達様式の洞察: 静脈注射 皮下投与 経口 全身性エリテマトーデス(SLE)治療薬市場について、投与形態に基づく詳細な分類と分析も行っている。これには静脈内投与、皮下投与、経口投与が含まれる。報告書によると、経口剤が最大の市場シェアを占めている。 地域別インサイト 北米 米国 カナダ アジア太平洋 中国 日本 インド 韓国 オーストラリア インドネシア その他 ヨーロッパ ドイツ フランス イギリス イタリア スペイン ロシア その他 ラテンアメリカ ブラジル メキシコ その他 中東・アフリカ また、北米(米国、カナダ)、アジア太平洋(中国、日本、インド、韓国、オーストラリア、インドネシア、その他)、欧州(ドイツ、フランス、英国、イタリア、スペイン、ロシア、その他)、中南米(ブラジル、メキシコ、その他)、中東・アフリカを含む主要地域市場についても包括的に分析している。報告書によると、北米は全身性エリテマトーデス(SLE)治療薬の最大市場である。北米の全身性エリテマトーデス(SLE)治療薬市場を牽引している要因としては、医療へのアクセスが容易であること、SLEの早期診断・早期治療の利点に対する認識が高まっていること、様々なジェネリック医薬品が容易に入手可能であることなどが挙げられる。 競争環境: 本レポートでは、世界の全身性エリテマトーデス(SLE)治療薬市場における競争環境についても包括的に分析しています。主要企業の詳細プロフィールも掲載している。対象企業には、AstraZeneca Plc、Aurinia Pharmaceuticals Inc.、GSK plc、ImmuPharma Plcなどが含まれる。 本レポートで扱う主な質問 1.全身性エリテマトーデス(SLE)治療薬の世界市場規模は? 2.2024年から2032年にかけての全身性エリテマトーデス(SLE)治療薬の世界市場予測成長率は? 3.全身性エリテマトーデス(SLE)治療薬の世界市場を牽引する主要因は何か? 4.COVID-19が全身性エリテマトーデス(SLE)治療薬の世界市場に与えた影響は? 5.薬剤クラスに基づく全身性エリテマトーデス(SLE)治療薬の世界市場の内訳は? 6.全身性エリテマトーデス(SLE)治療薬の世界市場における投与形態別の内訳は? 7.全身性エリテマトーデス(SLE)治療薬の世界市場における主要地域は? 8.全身性エリテマトーデス(SLE)治療薬の世界市場における主要プレイヤー/企業は? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Systemic Lupus Erythematosus (SLE) Drugs Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Drug Class 6.1 Antimalarials Drugs 6.1.1 Market Trends 6.1.2 Key Segments 6.1.2.1 Chloroquine 6.1.2.2 Hydroxychloroquine 6.1.3 Market Forecast 6.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Cytotoxic and Immunosuppressive Drugs 6.3.1 Market Trends 6.3.2 Key Segments 6.3.2.1 Cyclophosphamide 6.3.2.2 Methotrexate 6.3.2.3 Mycophenolate Mofetil 6.3.2.4 Tacrolimus 6.3.2.5 Cyclosporine 6.3.3 Market Forecast 6.4 Biologics 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Others 6.5.1 Market Trends 6.5.2 Market Forecast 7 Market Breakup by Mode of Delivery 7.1 Intravenous 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Subcutaneous 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Oral 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Region 8.1 North America 8.1.1 United States 8.1.1.1 Market Trends 8.1.1.2 Market Forecast 8.1.2 Canada 8.1.2.1 Market Trends 8.1.2.2 Market Forecast 8.2 Asia-Pacific 8.2.1 China 8.2.1.1 Market Trends 8.2.1.2 Market Forecast 8.2.2 Japan 8.2.2.1 Market Trends 8.2.2.2 Market Forecast 8.2.3 India 8.2.3.1 Market Trends 8.2.3.2 Market Forecast 8.2.4 South Korea 8.2.4.1 Market Trends 8.2.4.2 Market Forecast 8.2.5 Australia 8.2.5.1 Market Trends 8.2.5.2 Market Forecast 8.2.6 Indonesia 8.2.6.1 Market Trends 8.2.6.2 Market Forecast 8.2.7 Others 8.2.7.1 Market Trends 8.2.7.2 Market Forecast 8.3 Europe 8.3.1 Germany 8.3.1.1 Market Trends 8.3.1.2 Market Forecast 8.3.2 France 8.3.2.1 Market Trends 8.3.2.2 Market Forecast 8.3.3 United Kingdom 8.3.3.1 Market Trends 8.3.3.2 Market Forecast 8.3.4 Italy 8.3.4.1 Market Trends 8.3.4.2 Market Forecast 8.3.5 Spain 8.3.5.1 Market Trends 8.3.5.2 Market Forecast 8.3.6 Russia 8.3.6.1 Market Trends 8.3.6.2 Market Forecast 8.3.7 Others 8.3.7.1 Market Trends 8.3.7.2 Market Forecast 8.4 Latin America 8.4.1 Brazil 8.4.1.1 Market Trends 8.4.1.2 Market Forecast 8.4.2 Mexico 8.4.2.1 Market Trends 8.4.2.2 Market Forecast 8.4.3 Others 8.4.3.1 Market Trends 8.4.3.2 Market Forecast 8.5 Middle East and Africa 8.5.1 Market Trends 8.5.2 Market Breakup by Country 8.5.3 Market Forecast 9 Drivers, Restraints, and Opportunities 9.1 Overview 9.2 Drivers 9.3 Restraints 9.4 Opportunities 10 Value Chain Analysis 11 Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12 Price Analysis 13 Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players 13.3.1 AstraZeneca Plc 13.3.1.1 Company Overview 13.3.1.2 Product Portfolio 13.3.1.3 Financials 13.3.1.4 SWOT Analysis 13.3.2 Aurinia Pharmaceuticals Inc. 13.3.2.1 Company Overview 13.3.2.2 Product Portfolio 13.3.2.3 Financials 13.3.3 GSK plc 13.3.3.1 Company Overview 13.3.3.2 Product Portfolio 13.3.3.3 Financials 13.3.3.4 SWOT Analysis 13.3.4 ImmuPharma Plc 13.3.4.1 Company Overview 13.3.4.2 Product Portfolio 13.3.4.3 Financials 13.3.4.4 SWOT Analysis List of Figures Figure 1: Global: Systemic Lupus Erythematosus Drugs Market: Major Drivers and Challenges Figure 2: Global: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Billion US$), 2018-2023 Figure 3: Global: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032 Figure 4: Global: Systemic Lupus Erythematosus Drugs Market: Breakup by Drug Class (in %), 2023 Figure 5: Global: Systemic Lupus Erythematosus Drugs Market: Breakup by Mode of Delivery (in %), 2023 Figure 6: Global: Systemic Lupus Erythematosus Drugs Market: Breakup by Region (in %), 2023 Figure 7: Global: Systemic Lupus Erythematosus Drugs (Antimalarials Drugs) Market: Sales Value (in Million US$), 2018 & 2023 Figure 8: Global: Systemic Lupus Erythematosus Drugs (Antimalarials Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 9: Global: Systemic Lupus Erythematosus Drugs (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)) Market: Sales Value (in Million US$), 2018 & 2023 Figure 10: Global: Systemic Lupus Erythematosus Drugs (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 11: Global: Systemic Lupus Erythematosus Drugs (Cytotoxic and Immunosuppressive Drugs) Market: Sales Value (in Million US$), 2018 & 2023 Figure 12: Global: Systemic Lupus Erythematosus Drugs (Cytotoxic and Immunosuppressive Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 13: Global: Systemic Lupus Erythematosus Drugs (Biologics) Market: Sales Value (in Million US$), 2018 & 2023 Figure 14: Global: Systemic Lupus Erythematosus Drugs (Biologics) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 15: Global: Systemic Lupus Erythematosus Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023 Figure 16: Global: Systemic Lupus Erythematosus Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 17: Global: Systemic Lupus Erythematosus Drugs (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023 Figure 18: Global: Systemic Lupus Erythematosus Drugs (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 19: Global: Systemic Lupus Erythematosus Drugs (Subcutaneous) Market: Sales Value (in Million US$), 2018 & 2023 Figure 20: Global: Systemic Lupus Erythematosus Drugs (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 21: Global: Systemic Lupus Erythematosus Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023 Figure 22: Global: Systemic Lupus Erythematosus Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 23: North America: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 24: North America: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 25: United States: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 26: United States: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 27: Canada: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 28: Canada: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 29: Asia-Pacific: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 30: Asia-Pacific: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 31: China: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 32: China: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 33: Japan: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 34: Japan: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 35: India: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 36: India: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 37: South Korea: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 38: South Korea: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 39: Australia: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 40: Australia: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 41: Indonesia: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 42: Indonesia: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 43: Others: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 44: Others: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 45: Europe: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 46: Europe: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 47: Germany: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 48: Germany: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 49: France: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 50: France: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 51: United Kingdom: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 52: United Kingdom: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 53: Italy: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 54: Italy: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 55: Spain: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 56: Spain: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 57: Russia: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 58: Russia: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 59: Others: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 60: Others: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 61: Latin America: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 62: Latin America: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 63: Brazil: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 64: Brazil: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 65: Mexico: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 66: Mexico: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 67: Others: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 68: Others: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 69: Middle East and Africa: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 70: Middle East and Africa: Systemic Lupus Erythematosus Drugs Market: Breakup by Country (in %), 2023 Figure 71: Middle East and Africa: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 72: Global: Systemic Lupus Erythematosus Drugs Industry: Drivers, Restraints, and Opportunities Figure 73: Global: Systemic Lupus Erythematosus Drugs Industry: Value Chain Analysis Figure 74: Global: Systemic Lupus Erythematosus Drugs Industry: Porter's Five Forces Analysis List of Tables Table 1: Global: Systemic Lupus Erythematosus Drugs Market: Key Industry Highlights, 2023 & 2032 Table 2: Global: Systemic Lupus Erythematosus Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032 Table 3: Global: Systemic Lupus Erythematosus Drugs Market Forecast: Breakup by Mode of Delivery (in Million US$), 2024-2032 Table 4: Global: Systemic Lupus Erythematosus Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032 Table 5: Global: Systemic Lupus Erythematosus Drugs Market: Competitive Structure Table 6: Global: Systemic Lupus Erythematosus Drugs Market: Key Players
SummaryThe global systemic lupus erythematosus (SLE) drugs market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.83% during 2024-2032.The increasing number of patients suffering from SLE, rising public awareness campaigns, and the easy availability of generic drugs represent some of the key factors driving the market. Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Systemic Lupus Erythematosus (SLE) Drugs Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Drug Class 6.1 Antimalarials Drugs 6.1.1 Market Trends 6.1.2 Key Segments 6.1.2.1 Chloroquine 6.1.2.2 Hydroxychloroquine 6.1.3 Market Forecast 6.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Cytotoxic and Immunosuppressive Drugs 6.3.1 Market Trends 6.3.2 Key Segments 6.3.2.1 Cyclophosphamide 6.3.2.2 Methotrexate 6.3.2.3 Mycophenolate Mofetil 6.3.2.4 Tacrolimus 6.3.2.5 Cyclosporine 6.3.3 Market Forecast 6.4 Biologics 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Others 6.5.1 Market Trends 6.5.2 Market Forecast 7 Market Breakup by Mode of Delivery 7.1 Intravenous 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Subcutaneous 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Oral 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Region 8.1 North America 8.1.1 United States 8.1.1.1 Market Trends 8.1.1.2 Market Forecast 8.1.2 Canada 8.1.2.1 Market Trends 8.1.2.2 Market Forecast 8.2 Asia-Pacific 8.2.1 China 8.2.1.1 Market Trends 8.2.1.2 Market Forecast 8.2.2 Japan 8.2.2.1 Market Trends 8.2.2.2 Market Forecast 8.2.3 India 8.2.3.1 Market Trends 8.2.3.2 Market Forecast 8.2.4 South Korea 8.2.4.1 Market Trends 8.2.4.2 Market Forecast 8.2.5 Australia 8.2.5.1 Market Trends 8.2.5.2 Market Forecast 8.2.6 Indonesia 8.2.6.1 Market Trends 8.2.6.2 Market Forecast 8.2.7 Others 8.2.7.1 Market Trends 8.2.7.2 Market Forecast 8.3 Europe 8.3.1 Germany 8.3.1.1 Market Trends 8.3.1.2 Market Forecast 8.3.2 France 8.3.2.1 Market Trends 8.3.2.2 Market Forecast 8.3.3 United Kingdom 8.3.3.1 Market Trends 8.3.3.2 Market Forecast 8.3.4 Italy 8.3.4.1 Market Trends 8.3.4.2 Market Forecast 8.3.5 Spain 8.3.5.1 Market Trends 8.3.5.2 Market Forecast 8.3.6 Russia 8.3.6.1 Market Trends 8.3.6.2 Market Forecast 8.3.7 Others 8.3.7.1 Market Trends 8.3.7.2 Market Forecast 8.4 Latin America 8.4.1 Brazil 8.4.1.1 Market Trends 8.4.1.2 Market Forecast 8.4.2 Mexico 8.4.2.1 Market Trends 8.4.2.2 Market Forecast 8.4.3 Others 8.4.3.1 Market Trends 8.4.3.2 Market Forecast 8.5 Middle East and Africa 8.5.1 Market Trends 8.5.2 Market Breakup by Country 8.5.3 Market Forecast 9 Drivers, Restraints, and Opportunities 9.1 Overview 9.2 Drivers 9.3 Restraints 9.4 Opportunities 10 Value Chain Analysis 11 Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12 Price Analysis 13 Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players 13.3.1 AstraZeneca Plc 13.3.1.1 Company Overview 13.3.1.2 Product Portfolio 13.3.1.3 Financials 13.3.1.4 SWOT Analysis 13.3.2 Aurinia Pharmaceuticals Inc. 13.3.2.1 Company Overview 13.3.2.2 Product Portfolio 13.3.2.3 Financials 13.3.3 GSK plc 13.3.3.1 Company Overview 13.3.3.2 Product Portfolio 13.3.3.3 Financials 13.3.3.4 SWOT Analysis 13.3.4 ImmuPharma Plc 13.3.4.1 Company Overview 13.3.4.2 Product Portfolio 13.3.4.3 Financials 13.3.4.4 SWOT Analysis List of Figures Figure 1: Global: Systemic Lupus Erythematosus Drugs Market: Major Drivers and Challenges Figure 2: Global: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Billion US$), 2018-2023 Figure 3: Global: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032 Figure 4: Global: Systemic Lupus Erythematosus Drugs Market: Breakup by Drug Class (in %), 2023 Figure 5: Global: Systemic Lupus Erythematosus Drugs Market: Breakup by Mode of Delivery (in %), 2023 Figure 6: Global: Systemic Lupus Erythematosus Drugs Market: Breakup by Region (in %), 2023 Figure 7: Global: Systemic Lupus Erythematosus Drugs (Antimalarials Drugs) Market: Sales Value (in Million US$), 2018 & 2023 Figure 8: Global: Systemic Lupus Erythematosus Drugs (Antimalarials Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 9: Global: Systemic Lupus Erythematosus Drugs (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)) Market: Sales Value (in Million US$), 2018 & 2023 Figure 10: Global: Systemic Lupus Erythematosus Drugs (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 11: Global: Systemic Lupus Erythematosus Drugs (Cytotoxic and Immunosuppressive Drugs) Market: Sales Value (in Million US$), 2018 & 2023 Figure 12: Global: Systemic Lupus Erythematosus Drugs (Cytotoxic and Immunosuppressive Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 13: Global: Systemic Lupus Erythematosus Drugs (Biologics) Market: Sales Value (in Million US$), 2018 & 2023 Figure 14: Global: Systemic Lupus Erythematosus Drugs (Biologics) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 15: Global: Systemic Lupus Erythematosus Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023 Figure 16: Global: Systemic Lupus Erythematosus Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 17: Global: Systemic Lupus Erythematosus Drugs (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023 Figure 18: Global: Systemic Lupus Erythematosus Drugs (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 19: Global: Systemic Lupus Erythematosus Drugs (Subcutaneous) Market: Sales Value (in Million US$), 2018 & 2023 Figure 20: Global: Systemic Lupus Erythematosus Drugs (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 21: Global: Systemic Lupus Erythematosus Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023 Figure 22: Global: Systemic Lupus Erythematosus Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 23: North America: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 24: North America: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 25: United States: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 26: United States: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 27: Canada: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 28: Canada: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 29: Asia-Pacific: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 30: Asia-Pacific: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 31: China: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 32: China: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 33: Japan: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 34: Japan: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 35: India: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 36: India: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 37: South Korea: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 38: South Korea: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 39: Australia: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 40: Australia: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 41: Indonesia: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 42: Indonesia: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 43: Others: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 44: Others: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 45: Europe: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 46: Europe: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 47: Germany: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 48: Germany: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 49: France: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 50: France: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 51: United Kingdom: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 52: United Kingdom: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 53: Italy: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 54: Italy: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 55: Spain: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 56: Spain: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 57: Russia: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 58: Russia: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 59: Others: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 60: Others: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 61: Latin America: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 62: Latin America: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 63: Brazil: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 64: Brazil: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 65: Mexico: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 66: Mexico: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 67: Others: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 68: Others: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 69: Middle East and Africa: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million US$), 2018 & 2023 Figure 70: Middle East and Africa: Systemic Lupus Erythematosus Drugs Market: Breakup by Country (in %), 2023 Figure 71: Middle East and Africa: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million US$), 2024-2032 Figure 72: Global: Systemic Lupus Erythematosus Drugs Industry: Drivers, Restraints, and Opportunities Figure 73: Global: Systemic Lupus Erythematosus Drugs Industry: Value Chain Analysis Figure 74: Global: Systemic Lupus Erythematosus Drugs Industry: Porter's Five Forces Analysis List of Tables Table 1: Global: Systemic Lupus Erythematosus Drugs Market: Key Industry Highlights, 2023 & 2032 Table 2: Global: Systemic Lupus Erythematosus Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032 Table 3: Global: Systemic Lupus Erythematosus Drugs Market Forecast: Breakup by Mode of Delivery (in Million US$), 2024-2032 Table 4: Global: Systemic Lupus Erythematosus Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032 Table 5: Global: Systemic Lupus Erythematosus Drugs Market: Competitive Structure Table 6: Global: Systemic Lupus Erythematosus Drugs Market: Key Players
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
IMARC Services Private Limited. 社の最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/08 10:26 154.13 円 166.76 円 202.76 円 |